NCT05723107 2025-11-28EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)NYU Langone HealthPhase 1 Recruiting15 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT02671890 2025-01-07Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic CancerMayo ClinicPhase 1 Terminated16 enrolled
NCT06639724 2024-12-27Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic CancerUniversity of California, San DiegoPhase 1 Recruiting36 enrolled
NCT06346808 2024-04-04Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPCSichuan UniversityPhase 1 Not yet recruiting20 enrolled
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled